Home › Funds › Hood River Capital Management LLC › TGTX
Hood River Capital Management LLC position in TGTX
TG THERAPEUTICS INC · Health Care
Hood River Capital Management LLC reported holding 1,615,453 shares of TGTX (TG THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$90.1M, representing 0.76% of its reported portfolio and ranking #45 among its reported holdings. Hood River Capital Management LLC has disclosed TGTX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Hood River Capital Management LLC's TGTX position evolved
Hood River Capital Management LLC first disclosed a stake in TGTX in Q1 2024 at 1,474,037 shares (US$22.4M). The position peaked in Q3 2026 at 1,615,453 shares, worth US$90.1M. Across 11 filings, Hood River Capital Management LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,615,453 shares valued at US$90.1M — an increase of 14,943 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 1.47M | $22.42M | New |
| Q2 2024 | 1.57M | $27.98M | Add |
| Q3 2024 | 1.63M | $38.13M | Add |
| Q4 2024 | 1.46M | $43.81M | Reduce |
| Q1 2025 | 1.56M | $61.37M | Add |
| Q2 2025 | 1.57M | $56.41M | Add |
| Q3 2025 | 1.55M | $56.09M | Reduce |
| Q4 2025 | 1.58M | $47.14M | Add |
| Q1 2026 | 1.57M | $52.13M | Reduce |
| Q2 2026 | 1.60M | $87.93M | Add |
| Q3 2026 | 1.62M | $90.11M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TGTX and 13F data
TGTX (TG THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in TGTX — the largest reported positions include Soleus Capital Management, L.P. (US$160.9M), CONGRESS ASSET MANAGEMENT CO (US$145.4M), Opaleye Management Inc. (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TGTX
- Soleus Capital Management, L.P. 2.93M sh · $160.86M · Q2 2026
- CONGRESS ASSET MANAGEMENT CO 2.61M sh · $145.39M · Q3 2026
- Opaleye Management Inc. 535.00K sh · $29.39M · Q2 2026
- Penn Capital Management Company, LLC 480.88K sh · $26.88M · Q3 2026
More on Hood River Capital Management LLC
FAQ
How long has Hood River Capital Management LLC held TGTX?
Hood River Capital Management LLC has disclosed TGTX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Hood River Capital Management LLC's current position in TGTX?
As of Q3 2026, Hood River Capital Management LLC holds 1.62M shares of TGTX (TG THERAPEUTICS INC), valued at $90.11M, representing 0.76% of its reported portfolio and ranking #45.
Has Hood River Capital Management LLC been buying or selling TGTX?
In the latest 13F filing (Q3 2026), Hood River Capital Management LLC increased its position in TGTX. The position peaked in Q3 2026 at 1.62M shares.
Which other funds hold TGTX?
Other major institutional holders of TGTX include Soleus Capital Management, L.P., CONGRESS ASSET MANAGEMENT CO, Opaleye Management Inc., among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.